Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to -$6471.0.

  • BioScience Health Innovations' Change in Account Payables fell 55062.67% to -$6471.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1718.0, marking a year-over-year increase of 20935.71%. This contributed to the annual value of $551.0 for FY2024, which is 10722.15% up from last year.
  • According to the latest figures from Q3 2025, BioScience Health Innovations' Change in Account Payables is -$6471.0, which was down 55062.67% from $221.0 recorded in Q2 2025.
  • BioScience Health Innovations' Change in Account Payables' 5-year high stood at $8189.0 during Q1 2025, with a 5-year trough of -$14334.0 in Q2 2023.
  • For the 5-year period, BioScience Health Innovations' Change in Account Payables averaged around -$222.56, with its median value being $728.5 (2021).
  • The largest annual percentage gain for BioScience Health Innovations' Change in Account Payables in the last 5 years was 33791.4% (2025), contrasted with its biggest fall of 55062.67% (2025).
  • BioScience Health Innovations' Change in Account Payables (Quarter) stood at $3909.0 in 2021, then plummeted by 74.24% to $1007.0 in 2022, then tumbled by 332.67% to -$2343.0 in 2023, then soared by 90.57% to -$221.0 in 2024, then tumbled by 2828.05% to -$6471.0 in 2025.
  • Its last three reported values are -$6471.0 in Q3 2025, $221.0 for Q2 2025, and $8189.0 during Q1 2025.